RE:RE:RE:RE:RE:RE:Basher on Basher Bickering
In response to Geery's post... two reasons why 90 patients is important and why "it will" impact share price in a positive way.
First, Baxter is more than likely going to give Spectral a milestone payment once 90 is announced. It certainly won't be less than their first payment of $5 million and will probably be some multiple of $5 million.
Second... hopefully the test number for a positive outcome for patients will be disclosed. The necessary minimum number is 7% and hopefully the number will be 15% or greater.
Both of these facts will impact share price in a positive way. Personally, my best guesstimate is that the Canadian share price spikes to at least the 75 cent to $1.00 per share price.